Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other medical products for the healthcare industry in the United States, rest of North and South America, and internationally. More Details
Excellent balance sheet and fair value.
Share Price & News
How has Retractable Technologies's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: RVP's share price has been volatile over the past 3 months.
7 Day Return
US Medical Equipment
1 Year Return
US Medical Equipment
Return vs Industry: RVP exceeded the US Medical Equipment industry which returned 16.5% over the past year.
Return vs Market: RVP exceeded the US Market which returned 13.8% over the past year.
Price Volatility Vs. Market
How volatile is Retractable Technologies's share price compared to the market and industry in the last 5 years?
Simply Wall St News
6 days ago | Simply Wall StWe Wouldn't Rely On Retractable Technologies's (NYSEMKT:RVP) Statutory Earnings As A Guide
3 weeks ago | Simply Wall StWe Like These Underlying Trends At Retractable Technologies (NYSEMKT:RVP)
1 month ago | Simply Wall StDoes Retractable Technologies' (NYSEMKT:RVP) CEO Salary Compare Well With The Performance Of The Company?
Is Retractable Technologies undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: RVP ($6.38) is trading below our estimate of fair value ($12.97)
Significantly Below Fair Value: RVP is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: RVP is good value based on its PE Ratio (33.3x) compared to the US Medical Equipment industry average (49.1x).
PE vs Market: RVP is poor value based on its PE Ratio (33.3x) compared to the US market (17.6x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate RVP's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: RVP is overvalued based on its PB Ratio (6.5x) compared to the US Medical Equipment industry average (3.9x).
How is Retractable Technologies forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Retractable Technologies has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Examine whether Retractable Technologies is trading at an attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.
- Retractable Technologies competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Healthcare industry.
How has Retractable Technologies performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: RVP has a large one-off gain of $897.9K impacting its June 30 2020 financial results.
Growing Profit Margin: RVP became profitable in the past.
Past Earnings Growth Analysis
Earnings Trend: RVP has become profitable over the past 5 years, growing earnings by -9% per year.
Accelerating Growth: RVP has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: RVP has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (1.8%).
Return on Equity
High ROE: RVP's Return on Equity (21.1%) is considered high.
How is Retractable Technologies's financial position?
Financial Position Analysis
Short Term Liabilities: RVP's short term assets ($34.6M) exceed its short term liabilities ($11.0M).
Long Term Liabilities: RVP's short term assets ($34.6M) exceed its long term liabilities ($3.0M).
Debt to Equity History and Analysis
Debt Level: RVP's debt to equity ratio (11.7%) is considered satisfactory.
Reducing Debt: RVP's debt to equity ratio has increased from 10.8% to 11.7% over the past 5 years.
Debt Coverage: RVP's debt is well covered by operating cash flow (83.7%).
Interest Coverage: RVP earns more interest than it pays, so coverage of interest payments is not a concern.
What is Retractable Technologies's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate RVP's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate RVP's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if RVP's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if RVP's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of RVP's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Thomas Shaw (69 yo)
Mr. Thomas J. Shaw is Founder of Retractable Technologies, Inc. and serves as its Chief Executive Officer and President. Mr. Shaw has over 25 years of experience in industrial product design and has develo ...
CEO Compensation Analysis
Compensation vs Market: Thomas's total compensation ($USD505.13K) is below average for companies of similar size in the US market ($USD1.36M).
Compensation vs Earnings: Thomas's compensation has been consistent with company performance over the past year.
|VP, General Counsel & Secretary||no data||US$352.96k||1.09% |
|Vice President of Sales Development||no data||US$151.70k||0.040% |
|Executive Director of Global Health||no data||US$178.49k||0% |
|Director of Operations||22.67yrs||no data||no data|
|Director of National Accounts||no data||US$140.88k||no data|
Experienced Management: RVP's management team is seasoned and experienced (22.7 years average tenure).
|Independent Director||15.5yrs||US$6.00k||0.19% |
|Independent Director||12.83yrs||US$4.00k||0% |
|Independent Director||8.17yrs||US$6.00k||0.32% |
|Independent Director||3yrs||US$6.00k||0.013% |
Experienced Board: RVP's board of directors are seasoned and experienced ( 10.5 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: RVP insiders have sold more shares than they have bought in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Retractable Technologies, Inc.'s company bio, employee growth, exchange listings and data sources
- Name: Retractable Technologies, Inc.
- Ticker: RVP
- Exchange: AMEX
- Founded: 1994
- Industry: Health Care Supplies
- Sector: Healthcare
- Market Cap: US$210.777m
- Shares outstanding: 33.04m
- Website: https://www.retractable.com
Number of Employees
- Retractable Technologies, Inc.
- 511 Lobo Lane
- Little Elm
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|RVP||AMEX (NYSE MKT LLC)||Yes||Common Stock||US||USD||May 2001|
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other medical products for the healthcare industry in the United States, rest of North and South America, and ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/09/28 04:29|
|End of Day Share Price||2020/09/25 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.